Journal Article
. 2016 Jun; 11(6):e0158259.
doi: 10.1371/journal.pone.0158259.

Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers

Inna Tishchenko 1 Heloisa Helena Milioli 1 Carlos Riveros 2 Pablo Moscato 1 
  • PMID: 27341628
  •     77 References
  •     8 citations


Despite constituting approximately two thirds of all breast cancers, the luminal A and B tumours are poorly classified at both clinical and molecular levels. There are contradictory reports on the nature of these subtypes: some define them as intrinsic entities, others as a continuum. With the aim of addressing these uncertainties and identifying molecular signatures of patients at risk, we conducted a comprehensive transcriptomic and genomic analysis of 2,425 luminal breast cancer samples. Our results indicate that the separation between the molecular luminal A and B subtypes-per definition-is not associated with intrinsic characteristics evident in the differentiation between other subtypes. Moreover, t-SNE and MST-kNN clustering approaches based on 10,000 probes, associated with luminal tumour initiation and/or development, revealed the close connections between luminal A and B tumours, with no evidence of a clear boundary between them. Thus, we considered all luminal tumours as a single heterogeneous group for analysis purposes. We first stratified luminal tumours into two distinct groups by their HER2 gene cluster co-expression: HER2-amplified luminal and ordinary-luminal. The former group is associated with distinct transcriptomic and genomic profiles, and poor prognosis; it comprises approximately 8% of all luminal cases. For the remaining ordinary-luminal tumours we further identified the molecular signature correlated with disease outcomes, exhibiting an approximately continuous gene expression range from low to high risk. Thus, we employed four virtual quantiles to segregate the groups of patients. The clinico-pathological characteristics and ratios of genomic aberrations are concordant with the variations in gene expression profiles, hinting at a progressive staging. The comparison with the current separation into luminal A and B subtypes revealed a substantially improved survival stratification. Concluding, we suggest a review of the definition of luminal A and B subtypes. A proposition for a revisited delineation is provided in this study.

Luminal (Her2 negative) prognostic index and survival of breast cancer patients.
Xuesong Chen, Yingying Cong, +7 authors, Li Cai.
Cancer Epidemiol, 2014 Apr 15; 38(3). PMID: 24725965
An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.
Michael L Gatza, Grace O Silva, +2 authors, Charles M Perou.
Nat Genet, 2014 Aug 26; 46(10). PMID: 25151356    Free PMC article.
Highly Cited.
Gene expression profiling in breast cancer: classification, prognostication, and prediction.
Jorge S Reis-Filho, Lajos Pusztai.
Lancet, 2011 Nov 22; 378(9805). PMID: 22098854
Highly Cited. Review.
Biochemical and functional characterization of human phospholipid scramblase 4 (hPLSCR4).
Vincent Gerard Francis, Sathyanarayana N Gummadi.
Biol Chem, 2012 Oct 24; 393(10). PMID: 23089641
Mammary development meets cancer genomics.
Aleix Prat, Charles M Perou.
Nat Med, 2009 Aug 08; 15(8). PMID: 19661985
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.
Fabrice Sircoulomb, Nathalie Nicolas, +19 authors, Christophe Ginestier.
EMBO Mol Med, 2011 Feb 18; 3(3). PMID: 21328542    Free PMC article.
Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement.
Alan Mackay, Britta Weigelt, +7 authors, Jorge S Reis-Filho.
J Natl Cancer Inst, 2011 Mar 23; 103(8). PMID: 21421860    Free PMC article.
FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.
Gabriela Nestal de Moraes, Deborah Delbue, +9 authors, Raquel C Maia.
Cell Signal, 2015 Sep 26; 27(12). PMID: 26404623
Supervised risk predictor of breast cancer based on intrinsic subtypes.
Joel S Parker, Michael Mullins, +17 authors, Philip S Bernard.
J Clin Oncol, 2009 Feb 11; 27(8). PMID: 19204204    Free PMC article.
Highly Cited.
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes.
Patrick Maisonneuve, Davide Disalvatore, +10 authors, Aron Goldhirsch.
Breast Cancer Res, 2014 Jun 22; 16(3). PMID: 24951027    Free PMC article.
Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
Stéphanie Cornen, Arnaud Guille, +16 authors, Max Chaffanet.
PLoS One, 2014 Jan 15; 9(1). PMID: 24416132    Free PMC article.
A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation.
Sardar Faisal Mahmood, Nadège Gruel, +12 authors, Isabelle Bernard-Pierrot.
Carcinogenesis, 2013 Oct 24; 35(3). PMID: 24148822
The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
Zhi Hu, Ge Huang, +7 authors, Jian-Hua Mao.
Breast Cancer Res, 2010 Mar 10; 12(2). PMID: 20211017    Free PMC article.
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, +15 authors, D Botstein.
Nature, 2000 Aug 30; 406(6797). PMID: 10963602
Highly Cited.
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
Koei Chin, Sandy DeVries, +21 authors, Joe W Gray.
Cancer Cell, 2006 Dec 13; 10(6). PMID: 17157792
Highly Cited.
Remodelling the extracellular matrix in development and disease.
Caroline Bonnans, Jonathan Chou, Zena Werb.
Nat Rev Mol Cell Biol, 2014 Nov 22; 15(12). PMID: 25415508    Free PMC article.
Highly Cited. Review.
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.
A Psyrri, K T Kalogeras, +13 authors, G Fountzilas.
Ann Oncol, 2011 Nov 08; 23(6). PMID: 22056852
Challenges in projecting clustering results across gene expression-profiling datasets.
Lara Lusa, Lisa M McShane, +5 authors, Marco A Pierotti.
J Natl Cancer Inst, 2007 Nov 15; 99(22). PMID: 18000217
The molecular portraits of breast tumors are conserved across microarray platforms.
Zhiyuan Hu, Cheng Fan, +28 authors, Charles M Perou.
BMC Genomics, 2006 Apr 29; 7. PMID: 16643655    Free PMC article.
Highly Cited.
Iteratively refining breast cancer intrinsic subtypes in the METABRIC dataset.
Heloisa H Milioli, Renato Vimieiro, +3 authors, Pablo Moscato.
BioData Min, 2016 Jan 16; 9. PMID: 26770261    Free PMC article.
ROCK: a resource for integrative breast cancer data analysis.
Saif Ur-Rehman, Qiong Gao, Costas Mitsopoulos, Marketa Zvelebil.
Breast Cancer Res Treat, 2013 Jun 13; 139(3). PMID: 23756628
Breast tumor subgroups reveal diverse clinical prognostic power.
Zhaoqi Liu, Xiang-Sun Zhang, Shihua Zhang.
Sci Rep, 2014 Feb 07; 4. PMID: 24499868    Free PMC article.
Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease.
Aaron J Knox, Allison L Scaling, +4 authors, Kathryn B Horwitz.
Breast Cancer Res, 2014 Aug 15; 16(4). PMID: 25116921    Free PMC article.
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.
Da Wei Huang, Brad T Sherman, Richard A Lempicki.
Nucleic Acids Res, 2008 Nov 27; 37(1). PMID: 19033363    Free PMC article.
Highly Cited.
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
A Goldhirsch, E P Winer, +5 authors, Panel members.
Ann Oncol, 2013 Aug 07; 24(9). PMID: 23917950    Free PMC article.
Highly Cited.
Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years.
Masaaki Kawai, Kathleen E Malone, Mei-Tzu C Tang, Christopher I Li.
Cancer, 2014 Feb 12; 120(7). PMID: 24515648    Free PMC article.
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1.
Jiaquan Wu, Keith Mikule, +12 authors, Huawei Chen.
ACS Chem Biol, 2013 Jul 31; 8(10). PMID: 23895133
The molecular diversity of Luminal A breast tumors.
Giovanni Ciriello, Rileen Sinha, +5 authors, Nikolaus Schultz.
Breast Cancer Res Treat, 2013 Oct 08; 141(3). PMID: 24096568    Free PMC article.
Gelsolin Is Associated with Longer Metastasis-free Survival and Reduced Cell Migration in Estrogen Receptor-positive Breast Cancer.
Anna-Maria Stock, Franziska Klee, +10 authors, Frank Entschladen.
Anticancer Res, 2015 Sep 27; 35(10). PMID: 26408687
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.
Pratyaksha Wirapati, Christos Sotiriou, +10 authors, Mauro Delorenzi.
Breast Cancer Res, 2008 Jul 30; 10(4). PMID: 18662380    Free PMC article.
Highly Cited.
St. Gallen 2013: brief preliminary summary of the consensus discussion.
Nadia Harbeck, Christoph Thomssen, Michael Gnant.
Breast Care (Basel), 2013 Sep 04; 8(2). PMID: 24000280    Free PMC article.
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, +13 authors, David Botstein.
Proc Natl Acad Sci U S A, 2003 Jun 28; 100(14). PMID: 12829800    Free PMC article.
Highly Cited.
Expression and functional role of sprouty-2 in breast morphogenesis.
Valgardur Sigurdsson, Saevar Ingthorsson, +6 authors, Thorarinn Gudjonsson.
PLoS One, 2013 Apr 11; 8(4). PMID: 23573284    Free PMC article.
The molecular profile of luminal B breast cancer.
Chad J Creighton.
Biologics, 2012 Sep 08; 6. PMID: 22956860    Free PMC article.
Chromatin CKAP2, a new proliferation marker, as independent prognostic indicator in breast cancer.
Han-Seong Kim, Jae-Soo Koh, +12 authors, Kyeong-Man Hong.
PLoS One, 2014 Jun 03; 9(6). PMID: 24887265    Free PMC article.
Breast cancer molecular profiling with single sample predictors: a retrospective analysis.
Britta Weigelt, Alan Mackay, +5 authors, Jorge S Reis-Filho.
Lancet Oncol, 2010 Feb 26; 11(4). PMID: 20181526
Highly Cited.
JARID1B is a luminal lineage-driving oncogene in breast cancer.
Shoji Yamamoto, Zhenhua Wu, +19 authors, Kornelia Polyak.
Cancer Cell, 2014 Jun 18; 25(6). PMID: 24937458    Free PMC article.
Highly Cited.
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability.
S L Smith, N L Bowers, +6 authors, J Heighway.
Br J Cancer, 2005 Oct 14; 93(6). PMID: 16222316    Free PMC article.
Luminal breast cancer classification according to proliferative indices: clinicopathological characteristics and short-term survival analysis.
Yan Sun, Gang Nie, +3 authors, Haibo Wang.
Med Oncol, 2014 Jun 18; 31(7). PMID: 24935624
Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis.
Mitali Das, Shyam Babu Prasad, +5 authors, Gopeshwar Narayan.
PLoS One, 2013 Jul 23; 8(7). PMID: 23874974    Free PMC article.
Interval estimation for the difference between independent proportions: comparison of eleven methods.
R G Newcombe.
Stat Med, 1998 May 22; 17(8). PMID: 9595617
Highly Cited.
Mammary stem cells and the differentiation hierarchy: current status and perspectives.
Jane E Visvader, John Stingl.
Genes Dev, 2014 Jun 04; 28(11). PMID: 24888586    Free PMC article.
Highly Cited. Review.
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Anna Bergamaschi, Young H Kim, +6 authors, Jonathan R Pollack.
Genes Chromosomes Cancer, 2006 Aug 10; 45(11). PMID: 16897746
Highly Cited.
MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer.
Harriet E Gee, Francesca M Buffa, +17 authors, Timothy Molloy.
Int J Radiat Oncol Biol Phys, 2015 Nov 20; 93(5). PMID: 26581147
Highlights from the 14(th) St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer.
Angela Esposito, Carmen Criscitiello, Giuseppe Curigliano.
Ecancermedicalscience, 2015 May 02; 9. PMID: 25932042    Free PMC article.
Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information.
Zorka Inic, Milan Zegarac, +6 authors, Snezana Jancic.
Clin Med Insights Oncol, 2014 Sep 25; 8. PMID: 25249766    Free PMC article.
Network-based stratification of tumor mutations.
Matan Hofree, John P Shen, +2 authors, Trey Ideker.
Nat Methods, 2013 Sep 17; 10(11). PMID: 24037242    Free PMC article.
Highly Cited.
Cigarette smoking strongly modifies the association of complement factor H variant and the risk of lung cancer.
Zhi Zhang, Dianke Yu, +3 authors, Xuemei Zhang.
Cancer Epidemiol, 2011 Dec 27; 36(2). PMID: 22197220
Cellular calcium dynamics in lactation and breast cancer: from physiology to pathology.
Brandie M Cross, Gerda E Breitwieser, Timothy A Reinhardt, Rajini Rao.
Am J Physiol Cell Physiol, 2013 Nov 15; 306(6). PMID: 24225884    Free PMC article.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Christina Curtis, Sohrab P Shah, +29 authors, Samuel Aparicio.
Nature, 2012 Apr 24; 486(7403). PMID: 22522925    Free PMC article.
Highly Cited.
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.
Pascal Finetti, Nathalie Cervera, +7 authors, François Bertucci.
Cancer Res, 2008 Feb 05; 68(3). PMID: 18245477
Comprehensive molecular portraits of human breast tumours.
Cancer Genome Atlas Network.
Nature, 2012 Sep 25; 490(7418). PMID: 23000897    Free PMC article.
Highly Cited.
A three-gene model to robustly identify breast cancer molecular subtypes.
Benjamin Haibe-Kains, Christine Desmedt, +4 authors, Christos Sotiriou.
J Natl Cancer Inst, 2012 Jan 21; 104(4). PMID: 22262870    Free PMC article.
Highly Cited.
Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype.
Masumi Yanagawa, Kenzo Ikemot, +6 authors, Kohsuke Sasaki.
BMC Res Notes, 2012 Jul 27; 5. PMID: 22830453    Free PMC article.
The landscape of cancer genes and mutational processes in breast cancer.
Philip J Stephens, Patrick S Tarpey, +60 authors, Michael R Stratton.
Nature, 2012 Jun 23; 486(7403). PMID: 22722201    Free PMC article.
Highly Cited.
Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.
Yadav Sapkota, Sunita Ghosh, +5 authors, Sambasivarao Damaraju.
PLoS One, 2013 Jan 24; 8(1). PMID: 23342018    Free PMC article.
St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion.
Michael Gnant, Christoph Thomssen, Nadia Harbeck.
Breast Care (Basel), 2015 Jul 22; 10(2). PMID: 26195941    Free PMC article.
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Maggie C U Cheang, Stephen K Chia, +10 authors, Torsten O Nielsen.
J Natl Cancer Inst, 2009 May 14; 101(10). PMID: 19436038    Free PMC article.
Highly Cited.
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Paul L Nguyen, Alphonse G Taghian, +7 authors, Jay R Harris.
J Clin Oncol, 2008 Apr 17; 26(14). PMID: 18413639
Highly Cited.
An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential.
Jonathan M Goodwin, Robert U Svensson, +3 authors, Reuben J Shaw.
Mol Cell, 2014 Jul 22; 55(3). PMID: 25042806    Free PMC article.
Microenvironmental control of the breast cancer cell cycle.
Xun Guo, Yuehan Wu, Helen J Hathaway, Rebecca S Hartley.
Anat Rec (Hoboken), 2012 Jan 25; 295(4). PMID: 22271550    Free PMC article.
Meta-analysis of Aurora Kinase A (AURKA) Expression Data Reveals a Significant Correlation Between Increased AURKA Expression and Distant Metastases in Human ER-positive Breast Cancers.
Heinz-Ulli G Weier, Jian-Hua Mao.
J Data Mining Genomics Proteomics, 2014 Apr 15; 4(1). PMID: 24729942    Free PMC article.
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
Heloisa Helena Milioli, Renato Vimieiro, +3 authors, Pablo Moscato.
PLoS One, 2015 Jul 02; 10(7). PMID: 26132585    Free PMC article.
KIFC1 is a novel potential therapeutic target for breast cancer.
Yonghe Li, Wenyan Lu, +6 authors, Wei Zhang.
Cancer Biol Ther, 2015 Jul 16; 16(9). PMID: 26177331    Free PMC article.
Making breast cancer molecular subtypes robust?
Johan Staaf, Markus Ringnér.
J Natl Cancer Inst, 2014 Dec 07; 107(1). PMID: 25479803    Free PMC article.
Genomic profiling in luminal breast cancer.
Oleg Gluz, Daniel Hofmann, +3 authors, Nadia Harbeck.
Breast Care (Basel), 2014 Feb 20; 8(6). PMID: 24550749    Free PMC article.
Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
Lesleyann Hawthorn, Jesse Luce, Leighton Stein, Jenniffer Rothschild.
BMC Cancer, 2010 Aug 31; 10. PMID: 20799942    Free PMC article.
Methionine sulfoxide reductase A down-regulation in human breast cancer cells results in a more aggressive phenotype.
Antonella De Luca, Fabio Sanna, +7 authors, Bartolo Favaloro.
Proc Natl Acad Sci U S A, 2010 Oct 13; 107(43). PMID: 20937881    Free PMC article.
Differential patterns of recurrence and specific survival between luminal A and luminal B breast cancer according to recent changes in the 2013 St Gallen immunohistochemical classification.
A García Fernández, C Chabrera, +11 authors, N Giménez.
Clin Transl Oncol, 2014 Oct 02; 17(3). PMID: 25270605
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
Da Wei Huang, Brad T Sherman, Richard A Lempicki.
Nat Protoc, 2009 Jan 10; 4(1). PMID: 19131956
Highly Cited.
Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array.
Vinod Vathipadiekal, Victoria Wang, +5 authors, Michael Birrer.
Clin Cancer Res, 2015 May 07; 21(21). PMID: 25944803
Heterogeneity in breast cancer.
Kornelia Polyak.
J Clin Invest, 2011 Oct 04; 121(10). PMID: 21965334    Free PMC article.
Highly Cited.
Software for computing and annotating genomic ranges.
Michael Lawrence, Wolfgang Huber, +5 authors, Vincent J Carey.
PLoS Comput Biol, 2013 Aug 21; 9(8). PMID: 23950696    Free PMC article.
Highly Cited.
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses.
Geir Bredholt, Monica Mannelqvist, +9 authors, Lars A Akslen.
Oncotarget, 2015 Oct 21; 6(37). PMID: 26485755    Free PMC article.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, +14 authors, A L Børresen-Dale.
Proc Natl Acad Sci U S A, 2001 Sep 13; 98(19). PMID: 11553815    Free PMC article.
Highly Cited.
Human complement factor H is a novel diagnostic marker for lung adenocarcinoma.
Tiantian Cui, Yuan Chen, +7 authors, Iver Petersen.
Int J Oncol, 2011 Apr 20; 39(1). PMID: 21503575
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).
Michael Untch, Bernd Gerber, +28 authors, Anja Welt.
Breast Care (Basel), 2014 Jan 15; 8(3). PMID: 24415975    Free PMC article.
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes.
Heloisa H Milioli, Inna Tishchenko, +2 authors, Pablo Moscato.
BMC Med Genomics, 2017 Mar 30; 10(1). PMID: 28351365    Free PMC article.
Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.
Silvia J Serrano-Gómez, María Carolina Sanabria-Salas, +7 authors, Jovanny Zabaleta.
PLoS One, 2017 Aug 24; 12(8). PMID: 28832682    Free PMC article.
TEffectR: an R package for studying the potential effects of transposable elements on gene expression with linear regression model.
Gökhan Karakülah, Nazmiye Arslan, Cihangir Yandım, Aslı Suner.
PeerJ, 2019 Dec 12; 7. PMID: 31824778    Free PMC article.
Genomic Signatures in Luminal Breast Cancer.
Julian Puppe, Tabea Seifert, +3 authors, Wolfram Malter.
Breast Care (Basel), 2020 Sep 29; 15(4). PMID: 32982645    Free PMC article.
Analyzing the similarity of samples and genes by MG-PCC algorithm, t-SNE-SS and t-SNE-SG maps.
Xingang Jia, Qiuhong Han, Zuhong Lu.
BMC Bioinformatics, 2018 Dec 19; 19(1). PMID: 30558536    Free PMC article.
Quantification of intrinsic subtype ambiguity in Luminal A breast cancer and its relationship to clinical outcomes.
Neeraj Kumar, Dan Zhao, +2 authors, Peter H Gann.
BMC Cancer, 2019 Mar 10; 19(1). PMID: 30849944    Free PMC article.
The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer.
Theresa E Hickey, Luke A Selth, +21 authors, Wayne D Tilley.
Nat Med, 2021 Jan 20; 27(2). PMID: 33462444
Survival outcomes are associated with genomic instability in luminal breast cancers.
Lydia King, Andrew Flaus, Emma Holian, Aaron Golden.
PLoS One, 2021 Feb 04; 16(2). PMID: 33534788    Free PMC article.